Clinical Trials
23 trialsNCT02874430 2026-04-22
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Phase 2 Terminated
NCT02946996 2026-03-05
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Phase 2 Terminated
NCT03109847 2025-12-11
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Thomas Jefferson University
Phase 2 Terminated
NCT02500147 2025-07-02
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Columbia University
Phase 4 Terminated
NCT00984490 2024-02-01
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT03477162 2023-10-03
Metformin Pharmacology in Human Cancers: A Proof of Principle Study
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Terminated
NCT02420652 2023-02-08
PRIMA
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT02531308 2022-09-28
DLBCL
Rush University Medical Center
Phase 2 Terminated
NCT01482286 2022-03-15
PULSE
Pennington Biomedical Research Center
Phase 3 Terminated
NCT02495103 2021-01-26
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01627067 2020-06-19
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01717482 2020-03-10
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Mayo Clinic
Phase 2 Terminated
NCT02285855 2020-01-06
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02472353 2019-10-16
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
Phase 2 Terminated
NCT01849276 2019-01-31
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Northwestern University
Phase 1 Terminated
NCT01578551 2018-12-19
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT02019979 2018-05-04
METRO
Beth Israel Medical Center
Phase 2 Terminated
NCT02815397 2017-11-17
DLBCL
Rush University Medical Center
Phase 2 Terminated
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01215032 2017-05-15
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Phase 2 Terminated
NCT01632020 2016-07-11
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
University of Arkansas
Phase 2 Terminated
NCT01486043 2015-01-30
Metformin and Transient Hyperglycemia
Children's Hospital Los Angeles
Phase NA Terminated
NCT00682890 2014-08-20
Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
Virginia Commonwealth University
Phase 4 Terminated